A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: Parkinson's Disease

Treatments: Drug: Sinemet® controlled release (Carbidopa/levodopa)

Study type: Observational

Funder types: Industry

Identifiers

NCT00460954

CN158-001

Details and patient eligibility

About

The purpose of this clinical research study is to determine if different dosage regimens of Sinemet® CR (Carbidopa/levodopa) are dose proportional

Enrollment: 20 estimated patients

Sex: All

Ages: 50 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

• Key inclusion and exclusion criteria for healthy volunteers will be used
• Males and females aged 50-75